🇺🇸 FDA
Pipeline program

Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]

19-06-001

Approved small_molecule terminated

Quick answer

Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53] for Duchenne Muscular Dystrophy is a Approved program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sarepta Therapeutics
Indication
Duchenne Muscular Dystrophy
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials